AI assistant
Sanofi — M&A Activity 2004
Aug 23, 2004
1643_rns_2004-08-23_bc83734d-58e4-4611-8706-2d8150903742.html
M&A Activity
Open in viewerOpens in your device viewer
News Details
Takeover Bids | 23 August 2004 12:25
DGAP-WpÜG: Offeror: Sanofi-Aventis; Target: Hoechst AG (Part 2 of 2)
WpÜG-Mitteilung übermittelt durch die DGAP. Für den Inhalt der Mitteilung ist der Bieter verantwortlich. ——————————————————————————– Mandatory Publication pursuant to Sections 35 sub-sec. 1, 10 sub-sec. 3 Securities Acquisition and Takeover Act (WpÜG) – Mandatory Offer (Part 2 of 2) Offeror: Sanofi-Aventis 174 avenue de France 75013 Paris France ISIN FR 0000120578 (WKN 920 657) Target: Hoechst Aktiengesellschaft Industriepark Hoechst, Gebäude K 701 Brüningstraße 50 65926 Frankfurt am Main Germany ISIN DE 0005758007 (WKN 575 800) Other Companies directly affected by the Mandatory Offer: Aventis Cedex 9 67917 Strasbourg France ISIN FR 0000130460 (WKN 925 700) This announcement contains forward looking statements, which may be identified, inter alia, by words such as “intends”, “anticipates”, “will” or words of similar meaning. These statements are based on the current expectations of Sanofi-Aventis and are inherently subject to uncertainties and changes in circumstances, many of which are outside Sanofi-Aventis’ control. Actual events could differ materially from those described in the forward looking statements. Except as required by applicable law, Sanofi-Aventis does not undertake any obligation to update the forward-looking statements to reflect actual results, or any change in events, assumptions or other factors. This announcement was submitted to the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht; BaFin) and to the French Authority for Financial Markets (Autorité des Marchés Financiers; AMF) prior to the publication of this announcement pursuant to Sections 35 sub-sec. 1, 10 sub-sec. 4 WpÜG and article 7 of the provision no. 2002-04 of the COB (Commission des opérations de bourse), respectively. 23 August 2004 Sanofi-Aventis (for itself and for Total, L’Oréal, Téthys SAS, Ms Liliane Bettencourt, Mr André Bettencourt, Ms Françoise Bettencourt Meyers, Mr Jean- Pierre Meyers and Nestlé S.A.) Listings of Hoechst Aktiengesellschaft, Sanofi-Aventis and Aventis in the Federal Republic of Germany: Hoechst Aktiengesellschaft: Official Market in Frankfurt am Main, Over-The- Counter in Berlin-Bremen, Düsseldorf, Hamburg, Hanover, Munich and Stuttgart. Sanofi-Aventis: Over-The-Counter in Berlin-Bremen, Düsseldorf, Frankfurt am Main, Hamburg, Hanover, Munich and Stuttgart. Aventis: Official Market in Frankfurt am Main, Over-The-Counter in Berlin- Bremen, Düsseldorf, Hamburg, Hanover, Munich and Stuttgart. End part 2 of 2 Ende der Mitteilung (c)DGAP 23.08.2004 ——————————————————————————– Notiert: Sanofi-Aventis: Freiverkehr in Berlin-Bremen, Frankfurt, Hamburg, Hannover, München und Stuttgart; Hoechst AG: Amtlicher Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover, München und Stuttgart; Aventis S.A.: Amtlicher Markt in Frankfurt (General Standard); Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Hannover, München, Stuttgart; Paris 231225 Aug 04